Responses of Patients with Insulinomas to Stimulators and Inhibitors of Insulin Release That Have Been Linked with Cyclic Adenosine Monophosphate
Overview
Affiliations
Use of octreotide acetate for control of symptoms in patients with islet cell tumors.
Maton P World J Surg. 1993; 17(4):504-10.
PMID: 8395751 DOI: 10.1007/BF01655110.
Therapy of malignant hamster insulinomas with monoamine precursors.
Feldman J, Vervaert C, Klatt C, Seigler H Diabetologia. 1981; 20(2):148-54.
PMID: 6259010 DOI: 10.1007/BF00262019.
Gastroenteropancreatic endocrine tumors.
Weil C Klin Wochenschr. 1985; 63(10):433-59.
PMID: 2861306 DOI: 10.1007/BF01731493.
Defective regulation of insulin release and transmembrane Ca2+ fluxes by human islet cell tumours.
Flatt P, Powell C, Marks V Br J Cancer. 1987; 56(4):459-64.
PMID: 2825749 PMC: 2001822. DOI: 10.1038/bjc.1987.224.
Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors.
Maton P, Gardner J, Jensen R Dig Dis Sci. 1989; 34(3 Suppl):28S-39S.
PMID: 2537716 DOI: 10.1007/BF01536043.